Quarterly report pursuant to Section 13 or 15(d)

(Loss) earnings per share - Narrative (Details)

v3.22.2
(Loss) earnings per share - Narrative (Details) - shares
3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Earnings Per Share [Abstract]    
Antidilutive shares (in shares) 3,471,245 4,474,577